September 03, 2024
Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio
May 13, 2024
BULTAVO 3™ is a new vaccine that protects cattle and sheep against bluetongue virus serotype 3 (BTV-3)
April 25, 2024
World Veterinary Day 2024 celebrates the essential work of veterinarians, yet new data show only 49% of veterinary professionals believe their profession is appreciated
February 19, 2024
The Sleip app uses artificial intelligence (AI) to provide objective analysis of a horse’s movement with just a smartphone.
January 10, 2024
SENVELGO® wins Best New Product for Companion Animals award
November 23, 2023
Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats
September 05, 2023
New partnership working on solutions to combat African animal trypanosomiasis
August 14, 2023
Boehringer Ingelheim receives FDA approval for SENVELGO®: the first oral liquid medication for diabetes in cats
July 28, 2023
FRONTLINE® wins Brand of the Year Award for the third time in a row
July 20, 2023
Boehringer Ingelheim receives FDA approval for NexGard® PLUS: a beef-flavored soft chew that protects dogs from internal and external parasites
March 02, 2023
LastMile initiative reaches over 40,000 smallholder farmers in Sub-Saharan Africa increasing access to veterinary medicine
October 10, 2022
Bridging science and veterinary practice for swine health: The winners of the European PRRS Award 2022
September 06, 2022
Boehringer Ingelheim launches Fencovis®, a new vaccine to prevent calf diarrhea
June 14, 2022
Boehringer Ingelheim and CarthroniX announce partnership to pursue small molecule therapeutics in canine oncology
May 12, 2022
TwistPak®: Mixing platform for swine vaccines brings convenience and flexibility
April 21, 2022
Boehringer Ingelheim launches RenuTend™: a new stem cell therapy to improve the healing of tendon and suspensory ligament injuries in horses
March 22, 2022
Boehringer Ingelheim and the World Association for Buiatrics support outstanding research on ruminant animal health and well-being
February 09, 2022
New criteria for the susceptibility testing of Ubrolexin® when treating mastitis in dairy cows
January 18, 2022
Collaboration with MabGenesis to discover and develop novel monoclonal antibodies in canine
October 20, 2021
Aservo® EquiHaler® wins 2021 Pharmapack Award
October 11, 2021
Boehringer Ingelheim awards its first Translational Medicine Award
October 08, 2021
Boehringer Ingelheim to expand veterinary vaccine capacity for emerging and transboundary diseases in France
September 27, 2021
Boehringer Ingelheim and Invetx announce strategic collaboration
September 23, 2021
2021 European PRRS Research Award winners announced
Media Contacts
Head of Global Media Relations
E-Mail:
harro.ten_wolde@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-181352
Senior Media Relations Manager
E-Mail:
tereza.urbankova@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-184817
Senior Media Relations Manager
E-Mail:
mark_william.valentiner@boehringer-ingelheim.com
Tel.: +49 (6132) 77-170136
Media Relations Manager
E-Mail:
valerie-chiara.nestle@boehringer-ingelheim.com
Phone Number:
+49 (7351) 54-175075
Head of Human Pharma Communications
E-Mail:
anthonia.aboyeji@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-172370
Head of Animal Health Communications
E-Mail:
Heidi.DeWit-Sommerfeld@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-171799
Head of Innovation Unit Communications
E-Mail: camilla.krogh_lauritzen@boehringer-ingelheim.com
Phone Number: +45 2272 4806